Explore more publications!

European Jobs Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Jobs Online.

Press releases published on October 8, 2025

EWF Announces Keynote Speakers for the 2025 Annual Conference
NYF Radio Awards® Welcomes Publisher and Media Expert Steve Ahern OAM to the 2026 Advisory Board
Indie Author Magazine Sponsors ProWritingAid’s Novel November Writing Challenge
Frank Mann selected for Top 25 Global Impact Leaders by IAOTP
Steve Wilson Reveals Strategic Blueprint for Enterprise AI Success
OGARAJETS Announces Retirement of Wayne Starling After Distinguished Career in Aviation
La’ James International College Introduces Meevo Booking System to Enhance Student Training and Client Experience
9th Annual Palm Springs Young Playwrights Festival Announces Open Call for Submissions and finds support from The Bent
Retail Logistics Industry Set for Strong Growth, Reaching $809.7 Billion by 2032 at 13.5% CAGR
Chart-Topping Singer-songwriter Fawn Unveils More Ghostly Grooves from Her Haunted Halloween Jams Music Anthology
American Marketing Association Launches Digital Credentialing Program to Empower Marketers
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
Nilo Therapeutics 啟動 1.01 億美元 A 輪融資,推進針對免疫疾病神經迴路的新型藥物研發,並任命 Kim Seth 為行政總裁
Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหา…
Nilo Therapeutics 启动 1.01 亿美元 A 轮融资,以推进靶向免疫疾病神经回路的新型药物研发,并任命 Kim Seth 为首席执行官
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
PAIRS Foundation Awarded $3.75 Million to Launch Iron Bond Fatherhood Initiative

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions